Prescription drug · ANDA
Gabapentin NDC 71337-269
Gabapentin 300 mg/1 · Capsule · Oral · Havix Group Inc d-b-a Aavis Pharmaceuticals
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71337-269-10 | 7133702691071337026910 | 1000 CAPSULE in 1 BOTTLE (71337-269-10)Marketed from Nov 7, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Gabapentin
- Generic name (nonproprietary)
- gabapentin
- Active ingredients
- Gabapentin — 300 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Havix Group Inc d-b-a Aavis PharmaceuticalsNDC labeler code 71337
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 219319
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 71337-269_799550dd-f5d1-4488-b540-21f24d48b5b8SPL ID 799550dd-f5d1-4488-b540-21f24d48b5b8SPL set ID ad6c10e6-fc39-4ca2-942f-a56c4457e144UNII 6CW7F3G59XUPC 0371337269102
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471337026910followed by a unit qualifier and the quantityPackage 71337-0269-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 71337-269
- What is NDC 71337-269?
- 71337-269 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by Havix Group Inc d-b-a Aavis Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Gabapentin.
- What is the active ingredient?
- Gabapentin.
- Who is the labeler?
- Havix Group Inc d-b-a Aavis Pharmaceuticals, NDC labeler code 71337. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Gabapentin?
- 562 other product NDCs are listed under this name. See all Gabapentin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Gabapentin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Gabapentin | Gabapentin 600 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | 60760-919 | 60760-0919-90 |
| Gabapentin | Gabapentin 800 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | 60760-943 | 60760-0943-3060760-0943-90 |
| gabapentin | Gabapentin 300 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4763 | 70518-4763-00 |
| Gabapentin | Gabapentin 100 mg/1 | CapsuleOral | Advanced Rx of Tennessee, LLC | 80425-0595 | 80425-0595-0180425-0595-0280425-0595-03+1 more |
| Gabapentin | Gabapentin 100 mg/1 | CapsuleOral | Cardinal Health 107, LLC | 55154-0581 | 55154-0581-00 |
| Gabapentin | Gabapentin 300 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4746 | 70518-4746-0070518-4746-0170518-4746-02+1 more |
| Gabapentin | Gabapentin 100 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4742 | 70518-4742-0070518-4742-02 |
| Gabapentin | Gabapentin 400 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4740 | 70518-4740-0070518-4740-01 |
| Gabapentin | Gabapentin 300 mg/1 | CapsuleOral | Cardinal Health 107, LLC | 55154-0580 | 55154-0580-00 |
| Gabapentin | Gabapentin 600 mg/1 | Tablet, CoatedOral | Coupler LLC | 67046-1233 | 67046-1233-03 |
Other NDCs under ANDA 219319
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Gabapentin | Gabapentin 100 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-640 |
| Gabapentin | Gabapentin 300 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-641 |
| Gabapentin | Gabapentin 400 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-642 |
| Gabapentin | Gabapentin 100 mg/1 | CapsuleOral | STALLION LABORATORIES PRIVATE LIMITED | 72737-005 |
| Gabapentin | Gabapentin 300 mg/1 | CapsuleOral | STALLION LABORATORIES PRIVATE LIMITED | 72737-006 |
| Gabapentin | Gabapentin 400 mg/1 | CapsuleOral | STALLION LABORATORIES PRIVATE LIMITED | 72737-007 |
| Gabapentin | Gabapentin 200 mg/1 | CapsuleOral | Pangea Pharmaceuticals, LLC | 81279-126 |